What this means
This is a planned study that has not reported results yet. It will check how common muscle loss is in these patients and whether myokines may help show or cause it.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site
The science
- Registered title
- Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
- Trial ID
- NCT07703683 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Diabetes, Obesity & Overweight, Cushing Syndrome, Metabolic Diseases, Endocrine Diseases, Sarcopenia, Sarcopenic Obesity
- What is tested
- GLP-1 Receptor Agonists
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Ages
- 18 Years to no maximum
- Dates
- First posted Jul 14, 2026 · updated Jul 14, 2026
Registry summary
Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.
.
Sites (1)
- Cliniques Universitaires Saint-Luc, Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, Belgium